SEC Form 3 · accession 0001687888-18-000001
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jul 26, 2018
Accepted (ET)
Jul 27, 2018 · 9:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc common | holding | — | — | — | 210,607 | D | ||
| Catalyst Biosciences Inc common | holding | — | — | — | 406,032 | I | Managed account |
Table II — derivative securities
No Table II lines on this filing.